A sweeping new study developed by The Texas Law Dog has pulled back the curtain on the hidden dangers of prescribed psychiatric drugs in the United States. While mental health awareness has grown and treatment rates have climbed, the findings reveal a troubling reality: misuse, dangerous side effects, and a surge of lawsuits tied to medications that were meant to heal.
This isn’t just a medical issue, it’s a public health crisis with legal, ethical, and societal consequences.
Mental Health Treatment on the Rise
- Between 2019 and 2021, the percentage of U.S. adults receiving mental health treatment rose from 19.2% to 21.6%.
- By February 2023, nearly 30% of adults reported symptoms of anxiety and/or depression.
- 23% of the U.S. population is now estimated to suffer from some form of mental illness.
Age Breakdown
- 18–44 year-olds saw the sharpest increase: from 18.5% to 23.2% (a 4.7% jump).
- Women aged 18–44 were significantly more likely than men to receive treatment.
- Adults 45+ showed no significant change in treatment rates.
- In 2021, treatment rates by age:
- 18–44 years: 23.2%
- 45–64 years: 21.2%
- 65+ years: 18.9%
America’s Mental Illness Hotspots
The study mapped where mental illness is most concentrated:
- Highest prevalence states: Oregon, Utah, West Virginia, and others.
- Lowest prevalence states: Hawaii, New Jersey, and Florida.
This geographic divide underscores how environment, access to care, and socioeconomic factors shape mental health outcomes.
Drugs Most Frequently Linked to Adverse Effects
The study highlights four major categories of psychiatric drugs with alarming side-effect profiles:
1. Stimulants (Adderall, Ritalin)
- Of 84,000 adults prescribed stimulants, 25% reported misuse.
- 9% developed stimulant use disorder.
- Misuse rates:
- Amphetamines (Adderall): 32%
- Methylphenidate (Ritalin): 10%
2. Antidepressants (SSRIs like Prozac, Zoloft)
- Linked to a 60% rise in youth suicide.
- FDA issued a boxed warning about risks in young patients.
- Adverse event reports:
- Zoloft (sertraline): 23,732 cases
- Lamictal (lamotrigine): 16,043 cases
3. Antipsychotics (Risperidone, Clozapine)
- Associated with:
- Tardive dyskinesia (involuntary movements)
- Metabolic syndrome (weight gain, diabetes risk)
- Neutropenia (dangerously low white blood cell counts)
- FDA even scrapped certain safety programs for clozapine after finding them ineffective.
4. GLP‑1 Receptor Agonists (Ozempic, Wegovy)
- Originally for diabetes/weight loss, now prescribed off-label for mental health.
- Of 181,238 adverse event reports, 8,240 (4.55%) involved GLP‑1 drugs.
- Side effects include: stress, insomnia, binge eating, vomiting, and nervousness.
Lawsuits and Legal Fallout
The study points to Suboxone as a prime example of legal battles tied to psychiatric drugs:
- Intended to treat opioid dependence.
- Lawsuits allege its acidic film formulation causes severe dental damage (tooth decay, infections, tooth loss).
- FDA added a dental risk warning in 2022.
- As of mid-2025, there are 890 pending lawsuits against manufacturer Indivior, citing:
- Failure to warn
- Design defects
- Negligence
- Breach of warranty
The Telehealth Boom and Its Risks
- During the pandemic, telehealth prescribing skyrocketed.
- Easier access meant patients could obtain powerful drugs with less oversight.
- This “prescription shopping” trend raised red flags, especially with drugs like GLP‑1 agonists.
- Many physicians worry that virtual prescribing has fueled misuse and overprescription.
The Big Pharma Question
The study also raises ethical concerns:
- Evidence suggests overdiagnosis and overprescription are driven by profit motives.
- Side effects are often underreported.
- Critics argue that patient well-being is secondary to revenue in the pharmaceutical industry.
The Bigger Picture
The findings from The Texas Law Dog paint a sobering picture:
- Psychiatric drugs can save lives, but misuse and misprescription are widespread.
- Side effects range from increased anxiety and insomnia to irreversible physical harm and suicide.
- Lawsuits are mounting, oversight is lagging, and patients are often left in the dark about risks.
For states hardest hit by mental illness, the study suggests that addressing root causes — poverty, trauma, lack of access to therapy — may be more effective than continuing to expand reliance on drugs that too often do more harm than good.
Key Takeaways
- Mental health treatment is rising fastest among young adults.
- Stimulants and antidepressants are the most misused or dangerous.
- Suboxone lawsuits highlight the legal risks of underreported side effects.
- Telehealth prescribing has created new vulnerabilities.
- Big Pharma’s influence looms large in overprescription trends.
Final Word
By compiling this data, The Texas Law Dog has provided a vital resource for patients, families, and policymakers. The study is more than a warning, it’s a call to action. Without stronger safeguards, America risks trading one health crisis for another, as the very drugs meant to heal become a source of harm.